Xtant Medical Launches OsteoFactor Pro

Xtant Medical commenced commercial launch of OsteoFactor Pro, a naturally occurring cocktail of allogeneic growth factors engineered to improve bone healing and support surgical success across orthopedic and spine procedures.

OsteoFactor Pro is a naturally derived, growth factor-rich formulation that enhances the biologic activity and regenerative potential of any orthobiologic scaffold. Its biphasic release profile—delivering an immediate bolus followed by sustained growth factor release—is designed to drive and stimulate the body’s key natural bone regeneration pathways including targeted angiogenesis, chemotaxis and osteogenesis throughout the healing process.

OsteoFactor Pro is an off-the-shelf, ready-to-use solution that integrates seamlessly with synthetic, allograft or autograft scaffolds. It provides surgeons with exceptional versatility and biologic performance to support a wide range of bone regeneration approaches.

OsteoFactor Pro is now available to Xtant Medical’s U.S. distribution network.

“This product reflects our commitment to advancing the science of healing through biologics that offer precision, flexibility, and meaningful clinical impact,” said Sean Browne, President and CEO of Xtant Medical.

Mark Schallenberger, COO of Xtant Medical added, “With the launch of OsteoFactor Pro, Xtant becomes the first vertically integrated company to offer solutions across all five major orthobiologic categories—demineralized bone matrix, cellular allografts, synthetics, structural allografts, and now growth factors. This milestone reflects our long-term commitment to innovation, scalability, and meeting the full spectrum of surgeon and patient needs in regenerative medicine.”

Source: Xtant Medical Holdings, Inc.